BHCM
KURA icon

Brevan Howard Capital Management’s Kura Oncology KURA Stock Holding History

Brevan Howard Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299K Sell
27,234
-57,341
-68% -$541K ﹤0.01% 1716
2026
Q1 		$688K Buy
84,575
+39,732
+89% +$341K 0.01% 1112
2025
Q4 		$466K Sell
44,843
-2,847
-6% -$29.9K 0.01% 1151
2025
Q3 		$422K Buy
47,690
+33,761
+242% +$241K ﹤0.01% 1379
2025
Q2 		$80.4K Buy
+13,929
New +$85.3K ﹤0.01% 1794
2024
Q1 		– Sell
-11,891
Closed -$171K – 1179
2023
Q4 		$171K Buy
+11,891
New +$117K ﹤0.01% 900

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Brevan Howard Capital Management's KURA Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Kura Oncology (KURA) stake by 68% in Q2 2026, selling an estimated $541K and leaving 27,234 shares worth $299K. The position accounts for ﹤0.01% of the portfolio, ranked #1716.

Brevan Howard Capital Management first reported a position in KURA in Q4 2023 and has held it in 6 quarters since. The position peaked at $688K in Q1 2026. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Brevan Howard Capital Management held 27,234 shares of Kura Oncology worth $299K as of Q2 2026.
  • Brevan Howard Capital Management sold 57,341 Kura Oncology shares in Q2 2026, an estimated $541K.
  • Kura Oncology made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1716 holding.
  • Brevan Howard Capital Management first reported a position in Kura Oncology in Q4 2023 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Kura Oncology position peaked at $688K in Q1 2026.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.